X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
PAOG is considering a partnership opportunity with a larger organization that has the potential to accelerate the ongoing development of RespRx.
Lead Product(s): Cannabidiol
Therapeutic Area: Pulmonary/Respiratory Diseases Product Name: RespRx
Highest Development Status: PreclinicalProduct Type: Small molecule
Partner/Sponsor/Collaborator: CBD pharmaceutical
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Partnership October 28, 2021
Details:
RelaxRX is available in 30mg Softgels and in an 1800mg Tincture. The CBD oil is 100% derived from full spectrum whole plant hemp oil and contains no added chemicals.
Lead Product(s): Cannabidiol
Therapeutic Area: Sleep Product Name: RelaxRX CBD
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable October 18, 2021
Details:
The master services agreement with a clinical research organization in the U.S. will support PAOG for initiating an investigational New Drug application (IND) with the Food and Drug Administration (FDA).
Lead Product(s): Cannabidiol
Therapeutic Area: Pulmonary/Respiratory Diseases Product Name: RespRx
Highest Development Status: IND EnablingProduct Type: Small molecule
Partner/Sponsor/Collaborator: Undiaclosed
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Agreement October 23, 2020
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] 
Market Place
